Singapore, Singapore

Anissa Anindya Widjaja

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Anissa Anindya Widjaja: Innovator in Kidney and Metabolic Disease Treatments

Introduction

Anissa Anindya Widjaja is a prominent inventor based in Singapore, known for her significant contributions to the fields of kidney injury and metabolic disease treatments. With a total of four patents to her name, she has made remarkable strides in medical innovation.

Latest Patents

Anissa's latest patents include groundbreaking methods for the treatment and prevention of kidney injury. These methods focus on inhibiting interleukin 11 (IL-11)-mediated signaling, providing new avenues for therapeutic intervention. Additionally, she has developed methods for treating and preventing metabolic diseases through similar mechanisms, showcasing her expertise in addressing critical health issues.

Career Highlights

Throughout her career, Anissa has worked with esteemed institutions such as the National University of Singapore and Singapore Health Services Pte Ltd. Her work in these organizations has allowed her to collaborate with leading experts in the medical field and contribute to significant advancements in healthcare.

Collaborations

Anissa has had the opportunity to work alongside notable colleagues, including Stuart Alexander Cook and Sebastian Schaefer. These collaborations have further enriched her research and innovation efforts.

Conclusion

Anissa Anindya Widjaja stands out as a dedicated inventor whose work in kidney and metabolic disease treatments has the potential to impact many lives. Her innovative approaches and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…